JPMorgan Chase & Co’s Spero Therapeutics SPRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$684 Sell
236
-60,581
-100% -$176K ﹤0.01% 5775
2025
Q1
$43.8K Sell
60,817
-807
-1% -$581 ﹤0.01% 5072
2024
Q4
$63.5K Buy
61,624
+61,388
+26,012% +$63.2K ﹤0.01% 4932
2024
Q3
$316 Hold
236
﹤0.01% 5782
2024
Q2
$307 Hold
236
﹤0.01% 5709
2024
Q1
$406 Hold
236
﹤0.01% 5733
2023
Q4
$347 Hold
236
﹤0.01% 5938
2023
Q3
$286 Hold
236
﹤0.01% 5839
2023
Q2
$342 Hold
236
﹤0.01% 5670
2023
Q1
$0 Hold
236
﹤0.01% 6102
2022
Q4
$0 Sell
236
-1,352
-85% ﹤0.01% 5908
2022
Q3
$3K Buy
1,588
+313
+25% +$591 ﹤0.01% 5285
2022
Q2
$1K Sell
1,275
-79,897
-98% -$62.7K ﹤0.01% 5509
2022
Q1
$706K Sell
81,172
-16,013
-16% -$139K ﹤0.01% 3808
2021
Q4
$1.56M Sell
97,185
-7,749
-7% -$124K ﹤0.01% 3372
2021
Q3
$1.93M Sell
104,934
-10,922
-9% -$201K ﹤0.01% 3206
2021
Q2
$1.62M Buy
115,856
+47,287
+69% +$660K ﹤0.01% 3338
2021
Q1
$1.01M Sell
68,569
-5,106
-7% -$75.1K ﹤0.01% 3651
2020
Q4
$1.43M Sell
73,675
-16,213
-18% -$314K ﹤0.01% 3173
2020
Q3
$895K Sell
89,888
-9,887
-10% -$98.4K ﹤0.01% 3147
2020
Q2
$1.35M Buy
99,775
+21,669
+28% +$293K ﹤0.01% 2873
2020
Q1
$631K Sell
78,106
-55,172
-41% -$446K ﹤0.01% 3203
2019
Q4
$1.28M Sell
133,278
-33,448
-20% -$321K ﹤0.01% 2926
2019
Q3
$1.77M Buy
166,726
+2,337
+1% +$24.8K ﹤0.01% 2798
2019
Q2
$1.83M Buy
164,389
+13,814
+9% +$153K ﹤0.01% 2724
2019
Q1
$1.93M Sell
150,575
-35,601
-19% -$456K ﹤0.01% 2654
2018
Q4
$1.15M Buy
186,176
+9,693
+5% +$59.6K ﹤0.01% 2959
2018
Q3
$1.86M Buy
176,483
+37,840
+27% +$398K ﹤0.01% 2825
2018
Q2
$2.03M Sell
138,643
-117,710
-46% -$1.73M ﹤0.01% 2800
2018
Q1
$3.65M Buy
256,353
+255,052
+19,604% +$3.63M ﹤0.01% 2403
2017
Q4
$15K Buy
+1,301
New +$15K ﹤0.01% 4442